PR Distribution Report [30072015291457856847624559]

v.2.7

REPORT DETAILS
PR Distribution Report ID: 30072015291457856847624559
PR Distribution Campaign ID: 291457856847624559
Customer: yklinik@gmail.com
Press Release: “The Scientist” – the documentary about the life and work of Raphael Mechoulam link opens in a new window
Press Release language: English
PR released on: July 30, 2015
Report started on: July 30, 2015
Report last updated on: Aug 10, 2015*

* Frequent updates on your PR distribution report are only done during the active period of your PR campaign. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. You’ll be notified via an email if such an update has been made in future on your PR distribution report.
PR campaign duration:
The campaign duration depends on the PR distribution budget.
(Jul 30, 2015 – Aug 10, 2015 ~ 12 days)
Is PR campaign active?
The active period of your PR distribution campaign depends on the PR distribution budget.
No. The active period of your PR distribution campaign is over*.

Extend PR campaign & reach?


* Even if the active period of your PR distribution campaign is over, your press release remains alive and is up and running on EuropaWire and all the places it has been published on, released via, submitted to and appeared on. The active period of your PR distribution campaign depends on the PR distribution budget and can be anything between one week and 30+ days if larger PR distribution budgets are used. During the active period of your PR distribution campaign, EuropaWire uses its news-wire platform and market insights to proactively engage in leveraging some of today’s most sophisticated and precise multi-channel targeting options available online to source and reach out to the audience that might be interested in and engage with your PR message based on your targeting preferences. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
PR report observed period:
The observed period for the PR distribution report depends on the PR distribution campaign duration.
(Jul 30, 2015 – Aug 10, 2015 ~ 12 days)*

*The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
Report in progress: No
Report is completed: Yes
PR distribution budget: €99
Total reach: 73,404 (Jul 30, 2015 – Aug 10, 2015 ~ 12 days)
Reach level:
Indicates how optimal your reach is versus the average for the PR distribution budget employed.
Reach level~78%*

* Please note that while this indicator looks into how your reach performed towards the average for the same PR budget, targeting different countries, markets and audiences usually results in significantly different reach level for PR distribution campaigns with the same PR budgets.
TABLE OF CONTENT
1) Where did we publish on, release via and submit to…
2) Who did we target, where and how…
3) Who did we reach out to…
4) Who engaged…
5) Insights…
6) Extend…
WHERE DID WE PUBLISH…

Your press release has been published on, released via, submitted to, and appeared on EuropaWire, the Internet, Web, Search engines, the Blogosphere, News, News aggregators, Social media, etc.

Site URL
EuropaWire: Press release page:

https://news.europawire.eu/the-scientist-a-documentary-about-the-life-and-work-of-raphael-mechoulam-291457856847624559/eu-press-release/2015/07/30/

Categories:

https://news.europawire.eu/all-press-releases-in/chemicals/
https://news.europawire.eu/all-press-releases-in/healthcare/
https://news.europawire.eu/all-press-releases-in/media/
https://news.europawire.eu/all-press-releases-in/non-profit/
https://news.europawire.eu/all-press-releases-in/science/
https://news.europawire.eu/all-press-releases-in/society/

Tags:

https://news.europawire.eu/press-releases-tagged-with/anandamide/
https://news.europawire.eu/press-releases-tagged-with/biology/
https://news.europawire.eu/press-releases-tagged-with/cannabinoids/
https://news.europawire.eu/press-releases-tagged-with/cbd/
https://news.europawire.eu/press-releases-tagged-with/chemistry/
https://news.europawire.eu/press-releases-tagged-with/documentary/
https://news.europawire.eu/press-releases-tagged-with/endocannabinoid-system/
https://news.europawire.eu/press-releases-tagged-with/israel/
https://news.europawire.eu/press-releases-tagged-with/medical-marijuana/
https://news.europawire.eu/press-releases-tagged-with/medicinal-cannabis/
https://news.europawire.eu/press-releases-tagged-with/prescribed-grass/
https://news.europawire.eu/press-releases-tagged-with/professor-raphael-mechoulam/
https://news.europawire.eu/press-releases-tagged-with/raphael-mechoulam/
https://news.europawire.eu/press-releases-tagged-with/thc/
https://news.europawire.eu/press-releases-tagged-with/the-scientist/
https://news.europawire.eu/press-releases-tagged-with/worlds-most-misunderstood-plant/
https://news.europawire.eu/press-releases-tagged-with/zach-klein/

Google: https://www.google.com/search?hl=en&noj=1
Blogosphere: https://www.google.com/search?tbm=blg&hl=en&biw=
Twitter: https://twitter.com/europawire
https://twitter.com/europawire/status/626725730404179968
https://twitter.com/europawire/status/626743618611609600
https://twitter.com/europawire/status/626741826192433152
https://twitter.com/hashtag/documentary?src=hash
https://twitter.com/hashtag/Mechoulam?src=hash
https://twitter.com/hashtag/film?src=hash
https://twitter.com/hashtag/scientist?src=hash
https://twitter.com/hashtag/anandamide?src=hash
Facebook: https://www.facebook.com/EuropaWire
https://www.facebook.com/EuropaWire/posts/722194324592695
https://www.facebook.com/permalink.php?story_fbid=10…
https://www.facebook.com/mechoulamthescientist/posts/869062726501567
https://www.facebook.com/hashtag/hashish
https://www.facebook.com/hashtag/cannabis
https://www.facebook.com/hashtag/endocannabinoid
https://www.facebook.com/hashtag/anandamide
G+ https://plus.google.com/107823740277361235623
https://plus.google.com/b/107823740277361235623/107823740277361235623/posts/S1vcYMvtdXH
https://plus.google.com/s/%23marijuana
https://plus.google.com/s/%23health
https://plus.google.com/s/%23science
Yahoo Search: http://search.yahoo.com/search;…
Bing: http://www.bing.com/search?…
Pinterest: https://www.pinterest.com/europawire
https://www.pinterest.com/europawire/science/
https://www.pinterest.com/pin/399413060680799071/
Paper.li: https://paper.li/e-1431004197
Flipboard: https://flipboard.com/@europawire/
https://flipboard.com/@europawire/science-0tcm80agy
https://flipboard.com/topic/marijuana
WHO DID WE TARGET…
Countries, markets, verticals, audiences, interests, industries, categories, keywords, tags, etc.
Countries: Austria (EU)
Belgium (EU)
Bulgaria (EU)
Croatia (EU)
Cyprus (EU)
Czech Republic (EU)
Denmark (EU)
Estonia (EU)
Finland (EU)
France (EU)
Germany (EU)
Greece (EU)
Hungary (EU)
Ireland (EU)
Italy (EU)
Latvia (EU)
Lithuania (EU)
Luxembourg (EU)
Malta (EU)
Netherlands (EU)
Poland (EU)
Portugal (EU)
Romania (EU)
Slovakia (EU)
Slovenia (EU)
Spain (EU)
Sweden (EU)
United Kingdom (EU)
Language: English
Regions, Metros, DMAs, Cities, Towns, etc.: N/A
Industries: Chemicals, Healthcare, Media, Non Profit, Science, Society, etc.
Markets / Verticals: Biology, Documentary, etc.
Audiences: Internet, search engines and social media users living/residing in Austria (EU), Belgium (EU), Bulgaria (EU), Croatia (EU), Cyprus (EU), Czech Republic (EU), Denmark (EU), Estonia (EU), Finland (EU), France (EU), Germany (EU), Greece (EU), Hungary (EU), Ireland (EU), Italy (EU), Latvia (EU), Lithuania (EU), Luxembourg (EU), Malta (EU), Netherlands (EU), Poland (EU), Portugal (EU), Romania (EU), Slovakia (EU), Slovenia (EU), Spain (EU), Sweden (EU), United Kingdom (EU) using English language and with identified interests like chemistry, biology, cannabinoids, documentary, endocannabinoid system, medical marijuana, medicinal cannabis, science, etc.
Age: 18 and older
Gender: All
Interests: chemistry, biology, cannabinoids, documentary, endocannabinoid system, medical marijuana, medicinal cannabis, science, etc.
Categories, Keywords, Tags: Chemicals, Healthcare, Media, Non Profit, Science, Society, anandamide, biology, cannabinoids, CBD, chemistry, documentary, endocannabinoid system, Israel, medical marijuana, medicinal cannabis, Prescribed Grass, Professor Raphael Mechoulam, Raphael Mechoulam, THC, The Scientist, world’s most misunderstood plant, Zach Klein, etc.
Platforms: Desktop, mobile
WHO DID WE REACH OUT TO…
Total targeted reach, social media reach, followers, subscribers, etc.
Total generic reach: 1,776 people (Jul 30, 2015 – Aug 10, 2015 ~ 12 days)
Total targeted reach: 71,628 people (Jul 30, 2015 – Aug 10, 2015 ~ 12 days)
Total reach:
(generic + targeted)
73,404 people (Jul 30, 2015 – Aug 10, 2015 ~ 12 days)
Cost per PR total reach: €0.0013
Who did we reach: 71,628+ internet, search engines and social media users living/residing in Austria (EU), Belgium (EU), Bulgaria (EU), Croatia (EU), Cyprus (EU), Czech Republic (EU), Denmark (EU), Estonia (EU), Finland (EU), France (EU), Germany (EU), Greece (EU), Hungary (EU), Ireland (EU), Italy (EU), Latvia (EU), Lithuania (EU), Luxembourg (EU), Malta (EU), Netherlands (EU), Poland (EU), Portugal (EU), Romania (EU), Slovakia (EU), Slovenia (EU), Spain (EU), Sweden (EU), United Kingdom (EU) using English language and with identified interests like chemistry, biology, cannabinoids, documentary, endocannabinoid system, medical marijuana, medicinal cannabis, science, etc.
Combined number of followers the PR reached out to:
(Twitter, FB, G+, incl. re-tweets, likes, shares, etc.)
7,654+
Cost per follower reach: €0.012
High profile European influencers reached: 200+

(European/EU politicians, policy makers, government leaders, environmentalists, industrialists, bankers, financiers, c-level execs, top-level managers, professionals, consultants, analysts, investors, high networth individuals, etc.)
Cost per influencer reach: €0.495
WHO ENGAGED…
PR title views and displays, PR reads, engagements, social media insights, analytics and metrics, mentions, interactions, likes, tweets/retweets, shares, comments, replies, etc.
PR title views/displays: 73,404 people+
Cost per PR title view: €0.0013
PR total reads: 1,329* precisely targeted people read your press release
(Jul 30, 2015 – Aug 10, 2015 ~ 12 days**)

* The total PR reads number above is not final. It only covers the observed period for the PR distribution report, which is the active period of your PR campaign, which on itself depends on the PR distribution budget employed. The total number of people who will read your press release is highly likely to increase over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

** The observed period for the PR distribution report is tied up with the PR distribution budget used and covers the active period of your PR distribution campaign. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.
Cost per PR read: €0.074
PR title views / PR reads ratio: 1.81%
Who read your press release: 1,329 precisely targeted individuals living/residing in Austria (EU), Belgium (EU), Bulgaria (EU), Croatia (EU), Cyprus (EU), Czech Republic (EU), Denmark (EU), Estonia (EU), Finland (EU), France (EU), Germany (EU), Greece (EU), Hungary (EU), Ireland (EU), Italy (EU), Latvia (EU), Lithuania (EU), Luxembourg (EU), Malta (EU), Netherlands (EU), Poland (EU), Portugal (EU), Romania (EU), Slovakia (EU), Slovenia (EU), Spain (EU), Sweden (EU), United Kingdom (EU) that speak/read English and are interested in and like chemistry, biology, cannabinoids, documentary, endocannabinoid system, medical marijuana, medicinal cannabis, science, etc.
PR shares: 78
PR likes: 169
PR G+: 1
PR tweets/re-tweets/favorites: 7
PR reactions / comments:
EuropaWire, Search engines, news, Blogosphere, social media, etc.
7

* Please note that PR reactions and comments may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR reactions and comments, if any, may be included in future updates on this PR distribution report.
PR mentions:
Third party mentions online as a result of your press release on EuropaWire.
0

* Please note that PR mentions may happen way beyond the initial active PR distribution campaign period, which is covered by the current PR distribution report and such PR mentions, if any, may be included in future updates on this PR distribution report.
INSIGHTS…
PR insights, analyses, rates, averages, conclusions, etc.
Budget vs. target:
Reads vs. target:
Engagement vs. target:
Reach vs. budget:
Reads vs. budget:
Engagement vs. budget:
Reads vs. reach:
Engagement vs. reads:
Engagement vs. reach:
Language vs. target:
Reads vs. language:
Engagement vs. language:
Title vs. audience:
Title vs. target:
Reads vs. title:
EXTEND…
Extend PR distribution campaing to increase reach and engagement, etc.
Extend PR campaign & reach: Based on the PR distribution budget you choose from below, we’ll extend your existing PR distribution campaign for the same press release by using the same settings, preferences, targeting options, etc. The larger the PR distribution budget the longer both the PR distribution campaign and the observed period covered by your PR distribution report.



-END-
GENERAL NOTES:
Should you have any questions about this report, please contact us at info@europawire.eu.

Many of the figures, numbers and values included in the PR distribution report above are not final. The current PR distribution report only covers the active period of your PR distribution campaign, which on itself depends on the PR distribution budget employed. Many of the numbers above are highly likely to increase and change over time as your press release matures online and becomes more visible in the search engines, the blogoshpere and the social media space as well. Frequent updates are however only done during the active period of your PR distribution campaign, which is correlated to the PR distribution budget you’ve chosen and may be anything between one week and 30+ days with larger PR distribution budgets used. Further updates on this PR distribution report beyond the PR campaign period may be done on an irregular basis. If such an update is made on your PR distribution report in the future, EuropaWire will send a notification on the email address associated with this account.

Please note that while this PR distribution report is not behind secure page, it is not publicly accessible and unless you give the URL (the web address) away for other people to see it, there is no other way for somebody else to find it out on the Web. No sensitive, private or financial information, if ever made available to us, will ever be published in this report section.

The information in this PR distribution report was factually accurate on the date of its last update (date shown above). This PR distribution report remains on EuropaWire website for historical purposes only. EuropaWire assumes no duty to update the information to reflect subsequent developments beyond the period of the active PR distribution campaign. Readers should not rely upon the information in this PR distribution report as current or accurate after date it was last updated on.

To have an easy and quick access to this report page for further references, please consider bookmarking it.

Thank you for releasing via EuropaWire.

Editorial Staff
EuropaWire